Robert M. Weinrieb - Faculty Biosketch

Robert M. Weinrieb, M.D.

Professor of Psychiatry at the Hospital of the University of Pennsylvania

Attending Physician, Chief Psychiatric Consultant to the Penn Transplant Institute, University of Pennsylvania

Program Director, Consultation-Liaison Psychiatry (Psychosomatic Medicine) Fellowship (ACGME accredited), Hospital of the University of Pennsylvania, Philadelphia Veteran's Affairs Medical Center

Founder of Penn Medicine Total Recovery Outpatient Program for Liver Transplant Patients with Alcohol Use Disorders, Penn Presbyterian Hospital of the University of Pennsylvania

12c

Planning committee and clinical support for Integrated Liver transplant Engagement And Recovery Network (ILEARN), Co-Located, integrated Alcohol Use Disorders clinic for Hepatology and Psychiatry at the Hospital of the University of Pennsylvania

3 61

Department: Psychiatry

4 1 b

46 Contact information
58

Hospital of the University of Pennsylvania
1f c/o Ms. Kathy Kratowicz
22 2 Dulles, Liver Transplant
37 3400 Spruce St.
Philadelphia, PA 19104-6178

2e Office: 215-662-2858
32 Fax: 215-662-2244
24

Email:
robert.weinrieb@pennmedicine.upenn.edu

4 3 3 3 2 4 b 1f

13 Education:
21 9 B.A. 17 (Psychology) c
4b State University of New York at Buffalo , 1982.
21 9 M.D. c
5c State University of New York at Buffalo School of Medicine, 1987.
c

3 27

Links
b7 University of Pennsylvania and Philadelphia VA Consultation-Liaison Psychiatry Fellowship
c

5 21

1f Post-Graduate Training
24 32 Intern in Medicine, Neurology and Psychiatry 65 , St. Vincent's Hospital and Medical Center New York City, New York, 1987-1988.
24 1c Resident in Psychiatry 65 , St. Vincent's Hospital and Medical Center New York City, New York, 1988-1991.
24 f5 Postdoctoral Clinical Research Fellow, Department of Psychiatry, Treatment Research Center and The Philadelphia Veteran's Affairs Medical Center of the Center for the Studies of Addiction, University of Pennsylvania, 1991-1993.
c

3 25

17 Certifications
28 43 American Board of Psychiatry and Neurology, 1993.
28 30 American Board of Psychiatry and Neurology 30 Added Qualifications in Substance Abuse 16 , 1995.
28 94 American Board of Psychiatry and Neurology Added Qualifications in Consultation-Liaison Psychiatry (Psychosomatic Medicine), 2006.
28 94 American Board of Psychiatry and Neurology Added Qualifications in Consultation-Liaison Psychiatry (Psychosomatic Medicine), 2016.
c

3 90 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

7 29

Selected Publications

37 Zwiebel, S c Sudhakar E d5 Weinrieb RM: Substance Use Disorders in the Medically Ill. 4th edition of the American Psychiatric Association Textbook of Psychosomatic Medicine and Consultation Liaison Psychiatry Levenson, James L 53 (eds.). American Psychiatric Association Press, In Press 2026.

17e Weinrieb Robert, Medda Rituparna, Lucey Michael, R: Therapy of alcohol use disorder in liver transplant recipients. Liver Transplantation. Robert S. Brown, Jr. (eds.). Lippincott Williams & Wilkins (LWW) 31(4): 425-427, April 2025 Notes: On behalf of the American Association for the Study of Liver Diseases.

1c4 Nguyen L, Forte A, Malat G,Liu X, Rivera J, Christopher C, Samudralwar R, Ilori T, Bleicher M, Redfield RR III, Weinrieb R, Bloom RD, Dunn TB, Trofe-Clark J : Program Evaluation of Pharmacist-Performed Medication Adherence Assessments in Candidates for Living Donor Kidney Transplant. Progress in Transplantation. Rebecca P Winsett, PhD (eds.). Sage, 34(3): 141-147, August 2024.

1a1 Goswami-Banerjee A, Weinberg E, Coraluzzi L, Bitterman T, Nahas J, Addis S, Weinrieb R, Serper M: A tailored virtual program for alcohol use disorder treatment among liver transplant candidates and recipients is feasible and associated with lower post-transplant relapse. Clinical Transplantation. Ron Shapiro (eds.). Wiley, 38 (7), July 2024.

fd Robert M. Weinrieb, Michael A. Strong: Psychiatric Evaluation of the Liver Transplant Candidate with Alcohol Associated Hepatitis. Transplant Psychiatry: A Case-Based Approach to Clinical Challenges bd Zimbrean Paula; Sher Liza; Crone Catherine; DiMartini Andrea (eds.). Springer Nature, Page: 145-152, January 2023 Notes: DOI https://doi.org/10.1007/978-3-031-15052-4.

179 Deutsch-Link S, Bittermann T, Nephew L, Ross-Driscoll K, Weinberg EM, Weinrieb RM,Olthoff KM, Addis S, Serper M. : Racial and Ethnic Disparities in Psychosocial Evaluation and Liver Transplant Waitlisting. American Journal of Transplantation Page: https://doi.org/10.1016/j.ajt.2023.01.011, January 2023.

1b4 Jowsey-Gregoire S, Jannetto PJ, Jesse MT, Fleming J, Winder GS, Balliet W, Kuntz K, Vasquez A, Weinland S, Hussain F, Weinrieb R, Fireman M, Nickels MW, Peipert JD, Thomas C, Zimbrean PC: Substance use screening in transplant populations: Recommendations from a consensus workgroup. Transplantation Reviews. 36(2):100694, 2022 04. Elsevier Inc, 36(2), April 2022.

147 Weinrieb RM, DiMartini AF: The Role of Psychosocial Screening Tools in the Evaluation of Alcohol Associated Liver Transplant Patients. Liver Transplantation. Robert S. Brown, Jr. (eds.). American Association for the Study of Liver Diseases, March 6 2022.

ee Weinrieb Robert M, Lucey Michael R, Stanfield, Dylan: The Use of Marijuana by Liver Transplant Candidates and Recipients: is the smoke starting to clear? Digestive Medicine Research 86 Website: http://dmr.amegroups.com/ Zhou Sylvia, He Yulong, Jones Chris (eds.). AME Publishing, 4, September 2021.

18e Trofe-Clark J, Malat G, Norris M, Bleicher M, Smith E, Sawinski D, Weinrieb R, Bloom R: Comparison of Stanford Integrated Psychosocial Assessment for Transplantation Scores to Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant. American Transplant Congress June 2021.

2c

7 1d

2c back to top
26 Last updated: 11/05/2025
34 The Trustees of the University of Pennsylvania c